Bone marrow cells and myocardial regeneration.
Hematopoietic stem cell (HSC) plasticity and its clinical application have been studied profoundly in the past few years. Recent investigations indicate that HSC and other bone marrow stem cells can develop into other tissues. Because of the high morbidity and mortality of myocardial infarction and other heart disorders, myocardial regeneration is a good example of the clinical application of HSC plasticity in regenerative medicine. Preclinical studies in animals suggest that the use of this kind of treatment can reconstruct heart blood vessels, muscle, and function. Some clinical study results have been reported in the past 2 years. In 2003, reports of myocardial regeneration treatment increased significantly. Other studies include observations on the cell surface markers of transplanted cells and treatment efficacy. Some investigations, such as HSC testing, have focused on clinical applications using HSC plasticity and bone marrow transplantation to treat different types of disorders. In this review, we focus on the clinical application of bone marrow cells for myocardial regeneration.
Wang
Fu-Sheng
FS
R&D Department, Sysmex America, Mundelein, Illinois 60060, USA. wangf@sysmex.com
Trester
Cathy
C
D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation / Q000379:methods*; D006321:Heart / Q000502:physiology; D006412:Hematopoietic Stem Cells; D006801:Humans; D059630:Mesenchymal Stem Cells; D009206:Myocardium / Q000166:cytology*; D012038:Regeneration